echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Pro Pharma's new drug, antatory hydrochloride, gets FDA approval

    Pro Pharma's new drug, antatory hydrochloride, gets FDA approval

    • Last Update: 2020-06-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    recently, Plo Pharmaceuticals announced that its wholly-owned sub-
    company
    (http://Zhejiang Jutai Pharmaceutical Co., Ltdto the United States
    FDAto declare thenew drughttp:// (http://application (andA), that is, the U.Simitationpharmaceutical(http://application) has been approvedon hydrochloric acid amphetamine reprieve syltoss
    hydrochloric acid amphetamine reprieve sylline is suitable for the treatment of severe depression and seasonal affective disorder The Drug (http:// developed by VALEANT INTERNATIo nAL BARBADOS SR and launched in the United States on August 28, 2003 the main manufacturers of amphetamine-release tablets in the United States are PAR, TEVA, etc., and there is currently no product spree of the dosage form (http:// marketed   The antatone hydrochloric acid reprieve was developed by Plo Pharmaceuticals in cooperation with Tulex Pharmaceutical Co Ltd., Inc of the United States, and to date, Plo Pharmaceuticals has invested approximately $1.5 million in research and development on the amphetamine reprieve project   The antatone hydrochloride release tablet is the first generic drug approved by the FDA, and this time it has obtained FDA approval, marking prodruge's eligibility for sale in the U.S market
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.